Stereotactic Body Radiotherapy or Standard of Care for Prostate Oligoprogressive Cancer

NCT06927635 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Castrate Resistance Prostate Cancer
OligoProgressive Metastatic Disease

Interventions

RADIATION: Stereotactic Body Radiation Therapy (SBRT)
OTHER: Systemic therapy

Sponsor

University Health Network, Toronto